SLC9A9-AS2

Across TCGA pan-cancer cohorts, SLC9A9-AS2 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated SLC9A9-AS2 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher SLC9A9-AS2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SLC9A9-AS2 expression acts as an unfavorable survival marker, although some lineages such as PAAD and HNSC show a favorable association.

READ, STAD, and KIRP are the cancer types where SLC9A9-AS2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Tertile	III,IV	0.325	0.768	<.001	60	view →
STAD	DFS	Tertile	IV	0.137	0.548	<.001	45	view →
KIRP	DFS	Quartile	II,III,IV	0.094	0.616	<.001	39	view →
KIRC	DFS	Median	All	0.497	0.745	<.001	36	view →
PAAD	OS	Tertile	II,III,IV	1.000	0.443	.012	24	view →
UVM	OS	Tertile	All	0.284	0.612	.030	18	view →
BRCA	DFS	Tertile	All	0.921	0.953	.029	18	view →
HNSC	OS	Quartile	IV	0.560	0.369	.009	12	view →
KICH	OS	Median	II,III,IV	0.600	1.000	.027	10	view →
COAD	DFS	Tertile	III,IV	0.019	0.698	<.001	9	view →
SKCM	DFS	Tertile	All	0.435	0.624	.018	9	view →
ESCA	OS	Median	All	1.000	0.659	.020	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

SLC9A9-AS2–READ (OS)

Open the READ breakdown →